The study tested whether PF’3944 could maintain efficacy when switching from weekly to monthly injections and remain safe and well-tolerated
This is the first controlled pharmacologic study to demonstrate that treatment of obesity improved PsA disease measures
The seminar aimed to raise public awareness about inflammageing—chronic, low-grade inflammation that silently damages the body and accelerates ageing
The therapy -- Ryoncil (remestemcel-L-rknd) -- will be tested in adults with severe steroid-refractory acute graft-versus-host disease
Acquisition brings highly differentiated clinical-stage obesity candidates with potential to reshape the treatment landscape
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
Open a printable version of this pageEmail the URL of this page to a friend
Longest survival follow-up ever reported for immunotherapy treatment in this setting
Subscribe To Our Newsletter & Stay Updated
